Related Posts
Moderna stock more than doubles after melanoma vaccine trial shows “landmark moment”
Drugmaker Moderna’s stock more than doubled on Wednesday morning after the company announced a successful experimental mRNA vaccine to treat melanoma, the deadly skin cancer […]
